Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Pharmarise Holdings Corp. ( (JP:2796) ) has issued an announcement.
Pharmarise Holdings Corporation reported a significant increase in its financial performance for the first three months of the fiscal year ending May 31, 2026, with net sales rising by 10% year-on-year. Despite a net loss attributable to owners of the parent, the company achieved substantial growth in operating and ordinary profit, indicating improved operational efficiency and market positioning. The company’s financial outlook for the fiscal year remains positive, with expected growth in net sales and profits, reflecting its strategic focus on enhancing shareholder value.
The most recent analyst rating on (JP:2796) stock is a Hold with a Yen520.00 price target. To see the full list of analyst forecasts on Pharmarise Holdings Corp. stock, see the JP:2796 Stock Forecast page.
More about Pharmarise Holdings Corp.
Pharmarise Holdings Corporation operates in the pharmaceutical industry, focusing on the development, production, and distribution of pharmaceutical products. The company is listed on the Tokyo Stock Exchange and is known for its commitment to innovation and quality in healthcare solutions.
Average Trading Volume: 10,332
Technical Sentiment Signal: Hold
Current Market Cap: Yen6.14B
Learn more about 2796 stock on TipRanks’ Stock Analysis page.